Racial differences in serum chemokines in prostate cancer patients.

Cancer(2023)

引用 0|浏览8
暂无评分
摘要
Lower levels of CCL23 in AA prostate cancer patient sera and tumor tissues and high CXCL2 and CXCL5 may contribute to aggressive prostate cancer, as often seen in AA men. The disproportionate levels of serum chemokines associated with race warrant further exploration to improve equitability in precision oncology to benefit prostate cancer patients.
更多
查看译文
关键词
CCL23, chemokines profile, CXCL2, CXCL5, prostate cancer, racial disparity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要